Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage

Acta Neurochirurgica

Volumn 141, Issue 12, 1999, Pages 1331-1338

  Kawada, S ^a   Kinugasa, K ^a   Meguro, T ^d   Hirotsune, N ^b   Tokunaga, K ^c   Kamata, I ^b   Nakashima, H ^c   Ohmoto, T ^c  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Okayama Rehab Ctr Traum Apallics   (Japan)

^c Kousei Hospital   (Japan)

^d NONE

Author keywords

Cellulose acetate polymer; Cerebrospinal fluid drainage; Tissue type plasminogen activator; Vasospasm

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID DRAINAGE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; BASILAR ARTERY; CEREBRAL ANGIOGRAPHY; CEREBROSPINAL FLUID SHUNTS; COMBINED MODALITY THERAPY; FEMALE; INJECTIONS, INTRAVENTRICULAR; RABBITS; SUBARACHNOID HEMORRHAGE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR RESISTANCE; VASOSPASM, INTRACRANIAL;

EID: 0033403850     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050438     Document Type: Article

References (32)

1. 1. Findlay JM, Weir BKA, Steinke D, Tanabe T, Gordon P, Grace M (1988) Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69: 723-735
2. 2. Findlay JM, Weir BKA, Gordon P, Grace M, Baughman R (1989) Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24: 491 498
3. 3. Findlay JM, Weir BKA, Kanamaru K, Grace M, Gordon P, Baughman R, Howarth A (1989) Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature. Can J Neurol Sci 16: 28-40
4. 4. Findlay JM, Weir BKA, Kanamaru K, Grace M, Baughma R (1990) The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26: 201-206
5. 5. Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 181-188
6. 6. Findlay JM, Kassell NF, Weir BKA, Haley EC Jr, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg GK, West M, Winn HR, Ferguson G (1995) A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37: 168-178
7. 7. Inagawa T, Yamamoto M, Kamiya K (1990) Effect of clot removal on cerebral vasospasm. J Neurosurg 72: 224-230
8. 8. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL (1990) The international cooperative study on the timing of aneurysm surgery: part 1 - overall management results. J Neurosurg 73: 18-36
9. 9. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP (1990) The international cooperative study on the timing of aneurysm surgery: part 2 - surgical results. J Neurosurg 73: 37-47
10. 10. Kinugasa K, Mandai S, Terai Y, Kamata I, Sugiu K, Ohmoto T, Nishimoto A (1992) Direct thrombosis of aneurysms with cellulose acetate polymer: part II - preliminary clinical experience. J Neurosurg 77: 501-507
11. 11. Kinugasa K, Mandai S, Data I, Ohmoto T (1993) Direct thrombosis of aneurysms. J Neurosurg 78: 1007-1008 (Lett)
12. 12. Kinugasa K, Mandai S, Tsuchida S, Sugiu K, Kamata I, Tokunaga K, Ohmoto T, Taguchi K (1994) Cellulose acetate polymer thrombosis for the emergency treatment of aneurysms: Angiographic findings, clinical experience and histological study. Neurosurgery 34: 694-701
13. 13. Kinugasa K, Mandai S, Tsuchida S, Kumata I, Ohmoto T (1994) Direct thrombosis of a pseudoancurysm after obliteration of a carotid-cavernous fistula with cellulose acetate polymer: Technical case report. Neurosurgery 35: 755-760
14. 14. Kinugasa K, Kamata I, Hirotsune N, Tokunaga K, Sugiu K, Handa A, Nakashima H, Ohmoto T, Mandai S, Matsumoto Y (1995) Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. J Neurosurg 83: 34-41
15. 15. Kinugasa K, Mandai S, Kamata I, Tokunaga K, Sugiu K, Handa A, Nakashima H, Ohmoto T (1995) Prophylactic thrombosis to prevent new bleeding and to delay aneurysm surgery. Neurosurgery 36: 661-667
16. 16. Kodama N, Sasaki T, Kawakami M, Sato M, Yamanobe K, Watanabe Z, Yamao N (1990) Prevention of vasospasm: Cisternal irrigation therapy with urokinase and ascorbic acid. In: Sano K, Takakura K, Kassell NF, Sasaki T (eds) Cerebral Vasospasm. Proceedings of the IV International Conference of Cerebral Vasospasm. University of Tokyo Press, Tokyo, pp 292-296
17. 17. Mandai S, Kinugasa K, Ohmoto T (1992) Direct thrombosis of aneurysms with cellulose acetate polymer: Part I Results of thrombosis in experimental aneurysms. J Neurosurg 77: 497-500
18. 18. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T (1993) Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78: 430 437
19. 19. Mizukami M, Kawase T, Usami T, Tazawa T (1982) Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10: 301 307
20. 20. Ohman J, Servo A, Heiskanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 197-201
21. 21. Peterson EW, Choo SH, Lewis AJ, Lach B, Bormanis J (1980) Lysis of blood clot and experimental treatment of subarachnoid hemorrhage. In: Wilkins RH (ed) Cerebral arterial spasm. Williams and Wilkins, Baltimore, pp 625 627
22. 22. Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, Kondo A, Tanabe H, Nakamura J, Yamada K, Kobayashi N, Ohashi Y (1994) A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 35: 597 605
23. 23. Seifert V, Eisert WG, Stolke D, Goetz C (1989) Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25: 590 598
24. 24. Steinberg GK, Vanefsky MA, Marks MP, Adler JR Jr, Koenig GH (1994) Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 34: 809-814
25. 25. Stolke D, Seifert V (1992) Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30: 877-881
26. 26. Sugiu K, Kinugasa K, Mandai S, Tokunaga K, Ohmoto T (1995) Direct thrombosis of experimental aneurysms with cellulose acetate polymer. Technical aspects, angiographic follow up, and histological study. J Neurosurg 83: 531 538
27. 27. Suzuki J, Kodama N, Yoshimoto T, Mizoi K (1982) Ultraearly surgery of intracranial aneurysms. Acta Neurochir (Wien) 63: 185-191
28. 28. Taneda M (1982) Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg 57: 662 628
29. 29. Tokunaga K, Kinugasa K, Mandai S, Handa A, Hirotsune N, Ohmoto T (1998) Partial thrombosis of canine carotid bifurcation aneurysms with cellulose acetate polymer. Neurosurgery 42: 1135 1144
30. 30. Usui M, Saito N, Hoya K, Todo T (1994) Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34: 235-245
31. 31. Yagishita T, Nukui H, Kaneko M, Mitsuka S, Nishigaya K, Horikoshi T, Miyazawa N (1990) Effect of continuous cisternal drainage for symptomatic vasospasm, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm. Proceedings of the IV International Conference of Cerebral Vasospasm. University of Tokyo Press, Tokyo, pp 331 313
32. 32. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB (1991) Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 189 196